We use cookies to improve the performance of our site and optimize it for our users. Customize Cookie Preferences

Sign Up Today and Learn More About Curology Stock

Invest in or calculate the value of your shares in Curology or other pre-IPO companies through EquityZen's platform.

Get Started

Curology Stock (CURL)

Curology provides actual prescription skincare – customized for your skin and delivered to your door.

About Curology Stock

Founded

2014

Headquarters

San Francisco, CA, US

Total Funding

18.8M

Industries

Software, Data and Analytics, Artificial Intelligence

Curology makes prescription skincare affordable and accessible online, offering virtual consultations and custom formulas for acne and anti-aging. We believe clear skin can be life-changing — and should be accessible to everyone. But for 44 million acne sufferers in America, existing drugstore treatments too often fall short. Clinical trials tell us that certain prescription treatments may be more than twice as effective as using over-the-counter options for acne — but they can also be twice as expensive, requiring in-person visits to the dermatologist and high drug costs. Curology was founded by a mother-son team of dermatologists to bring effective acne care to more people, more affordably. We’ve assembled a committed team of dermatology providers and created a secure online platform, bringing professional acne care and prescription treatment to tens of thousands of people who wouldn’t otherwise be able to access or afford it.

Curology Press Mentions

Stay in the know about the latest news on Curology

Curology Management

Leadership team at Curology

SVP Marketing

Fabian Seelbach

Co-Founder and CEO

David Lortscher

Locked Features

Join now and verify your accreditation status to gain access to:

  • Curology current valuation
  • Curology stock price
  • Available deals in Curology and all other companies
  • Deal offering documents
  • EquityZen's proprietary data and insights, including
    • Cap tables, which include funding history by Share Class and Liquidity Preferences
    • Company Highlights
    • Business Model
    • Risk Factors
Join Now

How to invest in Curology stock?

Accredited investors can buy pre-IPO stock in companies like Curology through EquityZen funds. These investments are made available by existing Curology shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.

How to sell Curology stock?

Shareholders can sell their Curology stock through EquityZen's private company marketplace. EquityZen's network includes over 320K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.

If I invest, how do I exit my investment?

There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.

Why choose EquityZen?

Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 42K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."